Terms: = Breast cancer AND USP6, TRE2, 9098, ENSG00000129204, TRE17, Tre-2, HRP1 AND Prognosis
2 results:
1. Evaluation of non-genomic, clinical risk and survival results in endocrine-sensitive, HER-2 negative, lymph node negative breast cancer.
Baena Cañada JM; Gámez Casado S; Rodríguez Pérez L; Quílez Cutillas A; Cortés Carmona C; Rosado Varela P; Estalella Mendoza S; Ramírez Daffós P; Benítez Rodríguez E
Med Clin (Barc); 2018 Dec; 151(12):469-475. PubMed ID: 29501438
[TBL] [Abstract] [Full Text] [Related]
2. Antisense oligonucleotides to the epidermal growth factor receptor.
Witters L; Kumar R; Mandal M; Bennett CF; Miraglia L; Lipton A
Breast Cancer Res Treat; 1999 Jan; 53(1):41-50. PubMed ID: 10206071
[TBL] [Abstract] [Full Text] [Related]
